A detailed history of Jane Street Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jane Street Group, LLC holds 381,558 shares of AZN stock, worth $25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
381,558
Previous 268,685 42.01%
Holding current value
$25 Million
Previous $21 Million 41.88%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $8.65 Million - $9.89 Million
112,873 Added 42.01%
381,558 $29.7 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $23.8 Million - $28.7 Million
-355,639 Reduced 56.96%
268,685 $21 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $7.36 Million - $8.4 Million
120,677 Added 23.96%
624,324 $42.3 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $8.75 Million - $9.79 Million
141,331 Added 39.01%
503,647 $33.9 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $11 Million - $12.1 Million
-168,901 Reduced 31.8%
362,316 $24.5 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $3.35 Million - $3.64 Million
47,966 Added 9.93%
531,217 $38 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $13.5 Million - $15.3 Million
213,767 Added 79.32%
483,251 $33.5 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $6.6 Million - $8.58 Million
121,798 Added 82.47%
269,484 $18.3 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $3.47 Million - $8.89 Million
65,513 Added 79.73%
147,686 $8.1 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $3.47 Million - $8.89 Million
65,513 Added 79.73%
147,686 $8.1 Million
Q2 2022

Aug 16, 2022

SELL
$59.26 - $71.14 $2.68 Million - $3.21 Million
-45,192 Reduced 35.48%
82,173 $5.43 Million
Q1 2022

May 17, 2022

SELL
$55.72 - $67.12 $58.4 Million - $70.4 Million
-1,048,144 Reduced 89.17%
127,365 $8.45 Million
Q4 2021

Feb 15, 2022

SELL
$54.02 - $63.83 $1.13 Million - $1.33 Million
-20,897 Reduced 1.75%
1,175,509 $68.5 Million
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $20.2 Million - $22.1 Million
363,643 Added 43.67%
1,196,406 $71.9 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $4.23 Million - $5.25 Million
-87,315 Reduced 9.49%
832,763 $49.9 Million
Q1 2021

May 18, 2021

SELL
$47.16 - $54.44 $59.4 Million - $68.5 Million
-1,258,805 Reduced 57.77%
920,078 $45.7 Million
Q4 2020

Feb 17, 2021

BUY
$48.52 - $58.02 $63.3 Million - $75.7 Million
1,303,902 Added 149.02%
2,178,883 $109 Million
Q3 2020

Nov 17, 2020

BUY
$53.07 - $61.1 $40.1 Million - $46.2 Million
756,327 Added 637.42%
874,981 $47.9 Million
Q2 2020

Aug 17, 2020

BUY
$43.1 - $55.31 $4.4 Million - $5.65 Million
102,080 Added 615.9%
118,654 $6.28 Million
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $40.9 Million - $55.6 Million
-1,082,617 Reduced 98.49%
16,574 $740,000
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $10.9 Million - $13 Million
257,726 Added 30.63%
1,099,191 $54.8 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $4.03 Million - $4.57 Million
100,435 Added 13.55%
841,465 $37.5 Million
Q2 2019

Aug 15, 2019

BUY
$37.28 - $41.68 $25.4 Million - $28.4 Million
680,792 Added 1130.17%
741,030 $30.6 Million
Q1 2019

May 16, 2019

BUY
$35.49 - $43.02 $716,933 - $869,047
20,201 Added 50.46%
60,238 $2.44 Million
Q4 2018

Feb 15, 2019

BUY
$36.86 - $41.49 $867,942 - $976,965
23,547 Added 142.8%
40,037 $1.52 Million
Q3 2018

Nov 14, 2018

BUY
$34.76 - $39.72 $202,824 - $231,766
5,835 Added 54.76%
16,490 $653,000
Q2 2018

Aug 15, 2018

SELL
$34.55 - $37.05 $1.08 Million - $1.16 Million
-31,255 Reduced 74.58%
10,655 $374,000
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $815,315 - $905,823
24,729 Added 143.93%
41,910 $1.47 Million
Q4 2017

Feb 15, 2018

BUY
$32.09 - $34.78 $77,208 - $83,680
2,406 Added 16.28%
17,181 $596,000
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $427,884 - $502,350
14,775
14,775 $501,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.